Search research articles
Contact Us
Filters
Showing results (121-130 of 270) with videos related to
Page
of 27
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
March 30, 2023
Statistical Challenges when Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials
Carlee B Moser, Kara W Chew, Mark J Giganti, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 18, 2020
A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruption
Viviane M Andrade, Carla Mavian, Dunja Babic, et al.
Kidney International Reports
|
September 20, 2021
Nicotinamide Adenine Dinucleotide Biosynthetic Impairment and Urinary Metabolomic Alterations Observed in Hospitalized Adults With COVID-19-Related Acute Kidney Injury
Nathan H Raines, Matthew D Cheung, Landon S Wilson, et al.
The Journal of Clinical Investigation
|
January 29, 2019
Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy
Kevin B Einkauf, Guinevere Q Lee, Ce Gao, et al.
The Journal of Infectious Diseases
|
October 14, 2024
Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial
Kara W Chew, Brooke McGinley, Carlee Moser, et al.
Eclinicalmedicine
|
September 10, 2024
Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial
Teresa H Evering, Carlee Moser, Nikolaus Jilg, et al.
Mbio
|
February 24, 2021
Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment Interruption
Leila B Giron, Emmanouil Papasavvas, Xiangfan Yin, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 14, 2021
Virologic features of SARS-CoV-2 infection in children
Lael M Yonker, Julie Boucau, James Regan, et al.
The Journal of Infectious Diseases
|
October 14, 2021
Virologic Features of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children
Lael M Yonker, Julie Boucau, James Regan, et al.
The Journal of Antimicrobial Chemotherapy
|
March 11, 2021
Impact of pre-existing drug resistance on risk of virological failure in South Africa
Jonathan Z Li, Natalia Stella, Manish C Choudhary, et al.
Page
of 27
Search research articles
Search
Showing results (121-130 of 270) with videos related to
Sort By:
Page
of 27
Medrxiv : the Preprint Server for Health Sciences
|
March 30, 2023
Statistical Challenges when Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials
Carlee B Moser, Kara W Chew, Mark J Giganti, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 18, 2020
A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruption
Viviane M Andrade, Carla Mavian, Dunja Babic, et al.
Kidney International Reports
|
September 20, 2021
Nicotinamide Adenine Dinucleotide Biosynthetic Impairment and Urinary Metabolomic Alterations Observed in Hospitalized Adults With COVID-19-Related Acute Kidney Injury
Nathan H Raines, Matthew D Cheung, Landon S Wilson, et al.
The Journal of Clinical Investigation
|
January 29, 2019
Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy
Kevin B Einkauf, Guinevere Q Lee, Ce Gao, et al.
The Journal of Infectious Diseases
|
October 14, 2024
Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial
Kara W Chew, Brooke McGinley, Carlee Moser, et al.
Eclinicalmedicine
|
September 10, 2024
Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial
Teresa H Evering, Carlee Moser, Nikolaus Jilg, et al.
Mbio
|
February 24, 2021
Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment Interruption
Leila B Giron, Emmanouil Papasavvas, Xiangfan Yin, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 14, 2021
Virologic features of SARS-CoV-2 infection in children
Lael M Yonker, Julie Boucau, James Regan, et al.
The Journal of Infectious Diseases
|
October 14, 2021
Virologic Features of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children
Lael M Yonker, Julie Boucau, James Regan, et al.
The Journal of Antimicrobial Chemotherapy
|
March 11, 2021
Impact of pre-existing drug resistance on risk of virological failure in South Africa
Jonathan Z Li, Natalia Stella, Manish C Choudhary, et al.
Page
of 27